Quantbot Technologies’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-333
Closed -$7.24K 1963
2025
Q4
$7.24K Sell
333
-15,291
-98% -$438K ﹤0.01% 1610
2025
Q3
$509K Sell
15,624
-1,991
-11% -$73.5K 0.01% 1014
2025
Q2
$625K Buy
17,615
+906
+5% +$29.4K 0.02% 939
2025
Q1
$567K Buy
16,709
+5,177
+45% +$186K 0.02% 863
2024
Q4
$375K Buy
11,532
+8,500
+280% +$352K 0.01% 904
2024
Q3
$148K Buy
+3,032
New +$162K 0.01% 1089
2022
Q2
Sell
-10,900
Closed -$396K 1933
2022
Q1
$396K Buy
10,900
+10,800
+10,800% +$427K 0.03% 666
2021
Q4
$4K Buy
+100
New +$5.07K ﹤0.01% 1393
2021
Q3
Sell
-2,600
Closed -$106K 1715
2021
Q2
$106K Buy
+2,600
New +$88.4K 0.01% 894

Other funds holding LEGN

Quantbot Technologies's LEGN Position: Q1 2026 in Review

Quantbot Technologies sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 333 shares — an estimated $7.24K sold.

Quantbot Technologies first reported a position in LEGN in Q2 2021 and held it in 9 quarters. The position peaked at $625K in Q2 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Quantbot Technologies reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 333 Legend Biotech shares in Q1 2026, an estimated $7.24K.
  • Quantbot Technologies first reported a position in Legend Biotech in Q2 2021 and held it in 9 quarters.
  • Quantbot Technologies's Legend Biotech position peaked at $625K in Q2 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.